aTyr Pharma to Participate at the BMO Prescriptions for Success Healthcare Conference
December 07 2017 - 8:00AM
aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged
in the discovery and development of immuno-modulatory protein
therapeutics to treat patients suffering from rare, severe,
immune-mediated diseases, as well as various cancers, today
announced that the company will participate in a fireside chat at
the upcoming BMO Prescriptions for Success Healthcare Conference at
the Westin New York Grand Central Hotel in New York City on
Thursday, December 14, 2017, at 8:30 a.m. ET.
Links to a live audio webcast and replay of the fireside chat
discussion may be accessed on the aTyr website events page at:
http://investors.atyrpharma.com/events-and-webcasts. An audio
replay will be available for 90 days following the event.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and development of
innovative medicines for patients using its knowledge of
Physiocrine biology, a newly discovered set of immunological and
physiological pathways. To date, aTyr has generated three
innovative and unique development programs based on its knowledge
of the Resokine pathway to treat patients suffering from rare,
severe, immune-mediated diseases, as well as various cancers.
aTyr’s two lead programs, Resolaris and iMod.Fc, are agonists of
the Resokine pathway designed to temper immune engagement in
diseases characterized by excessive immune cell involvement. aTyr’s
third program, ORCA, represents a preclinical research program that
targets a novel, proprietary immuno-oncology pathway using
antibodies to enhance the immune response in tumor settings. aTyr
has built an intellectual property estate, to protect its pipeline,
comprising over 220 issued patents or allowed patent applications
that are owned or exclusively licensed, including over 300
potential Physiocrine-based protein compositions. For more
information, please visit http://www.atyrpharma.com.
Contact:Mark Johnson Sr.
Director, Investor Relationsmjohnson@atyrpharma.com858-223-1163
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2023 to Apr 2024